Apar Kishor Ganti, MD

Apar Kishor Ganti, MD, is a professor in the University of Nebraska Medical Center Division of Oncology & Hematology, the Dr. and Mrs. D. Leon UMNC Research Fund Chair in Internal Medicine, and the associate director for Clinical Research at the Fred & Pamela Buffett Cancer Center

Articles by Apar Kishor Ganti, MD

Apar Kishor Ganti, MD, professor, University of Nebraska Medical Center (UNMC) Division of Oncology & Hematology, Dr. and Mrs. D. Leon UMNC Research Fund Chair in Internal Medicine, associate director, Clinical Research, Fred & Pamela Buffett Cancer Center; Allison Cushman-Vokoun, MD, PhD, FCAP, Henry F. Krous Professor of Pathology, professor, UNMC Department of Pathology, Microbiology and Immunology, director, Division of Diagnostic Molecular Pathology and Human Genetics, medical director, Molecular Diagnostics and Personalized Medicine Laboratory, Nebraska Medicine, director, Molecular Genetic Pathology Fellowship Program, associate director, UMNC MD-PhD Scholars Program

FDA Approval Insights: Oncomine DX Express Test Companion Diagnostic for Sunvozertinib in Non–Small Cell Lung Cancer: With Apar Kishor Ganti, MD; and Allison Cushman-Vokoun, MD, PhD, FCAP

ByApar Kishor Ganti, MD,Allison Cushman-Vokoun, MD, PhD, FCAP

July 14th 2025

Drs Ganti and Cushman discuss the launch of the Oncomine DX Express Test, as well as the benefits and limitations of rapid next-generation sequencing.

Apar Kishor Ganti, MD, professor, University of Nebraska Medical Center Division of Oncology & Hematology, Dr. and Mrs. D. Leon UMNC Research Fund Chair in Internal Medicine, associate director, Clinical Research, Fred & Pamela Buffett Cancer Center

Dr Ganti on the Importance of Molecular Testing in NSCLC

ByApar Kishor Ganti, MD

July 10th 2025

Apar Kishor Ganti, MD, discusses the importance of molecular testing in NSCLC and the profiling capabilities of the Oncomine DX Express Test.

Dr. Ganti on Lung Cancer Abstracts From the 2018 ASCO Annual Meeting

ByApar Kishor Ganti, MD

July 12th 2018

Apar Kishor Ganti, MD, professor of internal medicine, Division of Oncology/Hematology, University of Nebraska Medical Center, discusses lung cancer abstracts that were presented at the 2018 ASCO Annual Meeting.

Latest Updated Articles

Dr. Ganti on Lung Cancer Abstracts From the 2018 ASCO Annual Meeting
Published: July 12th 2018 | Updated:

Apar Kishor Ganti, MD

Articles by Apar Kishor Ganti, MD

FDA Approval Insights: Oncomine DX Express Test Companion Diagnostic for Sunvozertinib in Non–Small Cell Lung Cancer: With Apar Kishor Ganti, MD; and Allison Cushman-Vokoun, MD, PhD, FCAP

Dr Ganti on the Importance of Molecular Testing in NSCLC

Dr. Ganti on Lung Cancer Abstracts From the 2018 ASCO Annual Meeting

Latest Updated Articles

Trending on OncLive

FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma

PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer

Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma

Dr Braunstein on the FDA Approval of Subcutaneous Daratumumab With VRd For Newly Diagnosed Multiple Myeloma

Ixazomib-Containing Combinations Signal Potential for More PI-Based Regimens in R/R Multiple Myeloma